Phase II study of biweekly cetuximab therapy for unresectable colorectal cancer
Phase 2
- Conditions
- unresectable colorectal cancer
- Registration Number
- JPRN-UMIN000011361
- Lead Sponsor
- Department of Surgical Oncology Osaka City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)other co-existing malignancy 2)severe concurrent medical orpsychiatric illness 3)patients were pregnant or lactating.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method Adverse event Disease control rate Disease free survival